References
- Hojer J, Karlson-Stiber C, Landgren A, et al. Paracetamol poisoning is getting more and more common. The Swedish Poison Information Centre raise the alarm–time for countermeasures. Lakartidningen. 2013;110:1870–1871.
- Bateman DN, Carroll R, Pettie J, et al. Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol. 2014;78:610–618.
- Concise [Internet]. Swedish eHealth Agency. 2000.
- GlaxoSmithKline. Alvedon modified-release tablet. Summary of Product Characteristics. 2016.
- Tan C, Graudins A. Comparative pharmacokinetics of panadol extend and immediate-release paracetamol in a simulated overdose model. Emerg Med Australas. 2006;18:398–403.
- Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol. 2012;50:91–98.
- Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975;55:871–876.
- Prescott LF, Park J, Ballantyne A, et al. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977;2:432–434.
- Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–1100.
- Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141:380–385.
- Graudins A, Chiew A, Chan B. Overdose with modified-release paracetamol results in delayed and prolonged absorption of paracetamol. Intern Med J. 2010;40:72–76.
- Graudins A. Overdose with modified-release paracetamol (Panadol Osteo®) presenting to a metropolitan emergency medicine network: a case series. Emerg Med Australas. 2014;26:398–402.
- Vassallo S, Khan AN, Howland MA. Use of the Rumack-Matthew nomogram in cases of extended-release acetaminophen toxicity. Ann Intern Med. 1996;125:940
- Bizovi KE, Aks SE, Paloucek F, et al. Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief. Ann Emerg Med. 1996;28:549–551.
- Cetaruk EW, Dart RC, Horowitz RS, et al. Extended-release acetaminophen overdose. JAMA. 1996;275:686.
- Temple AR, Mrazik TJ. More on extended-release acetaminophen. N Engl J Med. 1995;333:1508–1509.
- Chiew AL, Fountain JS, Graudins A, et al. Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2015;203:215–218.
- Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977;5:445–479.
- Delyon B, Lavielle V, Moulines E. Convergence of a stochastic approximation version of the EM algorithm. Ann Stat 1999;27:94–128.
- Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28:481–504.
- Lystbaek BB, Norregaard P. [A case of paracetamol retard poisoning with fatal outcome]. Ugeskr Laeg. 1995;157:899–900.
- Graudins A, Aaron CK, Linden CH. Overdose of extended-release acetaminophen. N Engl J Med. 1995;333:196
- Cetaruk EW, Dart RC, Hurlbut KM, et al. Tylenol extended relief overdose. Ann Emerg Med. 1997;30:104–108.
- Roberts DM, Buckley NA. Prolonged absorption and delayed peak paracetamol concentration following poisoning with extended-release formulation. Med J Aust. 2008;188:310–311.
- Graudins A, Pham HN, Salonikas C, et al. Early presentation following overdose of modified-release paracetamol (Panadol Osteo) with biphasic and prolonged paracetamol absorption. N Z Med J. 2009;122:64–71.
- Vraa E, Watson W, Neau S, Dissolution of Tylenol® dosage formulations under overdose conditions. J Toxicol Clin Tox; 1995. p. 510–511.
- Hendrickson RG, McKeown NJ, West PL, et al. Bactrian acetaminophen pharmacokinetics: a case series and review of the literature. J Med Toxicol. 2010;6:337–344.
- Hoegberg L, Refsgaard F, Pedersen S, et al. Potential pharmacobezoar formation of extended-release tablets and their dissolution: an in vitro study, Abstract 44, EAPCCT XXXVII International Congress, 16–19 May 2017, Basel, Switzerland. Clin Toxicol. 2017;55:389–390.
- Halcomb SE, Sivilotti ML, Goklaney A, et al. Pharmacokinetic effects of diphenhydramine or oxycodone in simulated acetaminophen overdose. Acad Emerg Med. 2005;12:169–172.